bilaterals.org logo
bilaterals.org logo

medicines


Opposition mounts against regional trade pact threatening human rights
Less well known than the notorious Trans-Pacific Partnership, the Regional Comprehensive Economic Partnership (RCEP) is engendering growing opposition because of its similar oppressive provisions.
Alphachat podcast: Joe Stiglitz on minimum wage, monetary policy, TPP and more
Joseph Stiglitz, the Nobel Prize-winning economist, discusses TPP.
How Canada caved to US pressure at TPP talks in Hawaii
Negotiators dropped patent and copyright demands but failed to garner agreement.
EU, India working to resolve trade row over generic drugs
The EU and India are taking steps to end a trade row sparked by an EU ban of 700 Indian pharmaceutical products after New Delhi cancelled talks on a free trade accord earlier this month.
TPP in trouble: why we can win this fight!
Time is running out for a congressional vote on a completed TPP deal during President Obama’s term of office.
Why TPP threatens to undermine one of the fundamental principles of science
Data exclusivity is a kind of super-patent that is an incredibly powerful form of monopoly.
Why South Africa’s health minister is so worried about India caving in to big pharma
A big supplier of cheap lifesaving drugs to developing nations, India admirably balances public health needs with private profits and innovation. But it is under pressure to change this model.
India defers FTA talks with EU over ban of 700 drugs
Objecting to the ban of around 700 pharma products by the European Union, India said that it has called off a scheduled meeting of chief negotiators of the two sides on the proposed free trade agreement
Knowledge Ecology International leaks TPP text on intellectual property
Knowledge Ecology International released text from three sections of the 95-page secret negotiating text on the Intellectual Property Chapter being used in the Trans-Pacific Partnership Agreement trade negotiations
TPP: Key admits medicine costs will rise
Prime Minister John Key has conceded New Zealand will have to pay more for some medicines under the Trans-Pacific Partnership but he says it is in the country’s best interests
CAFTA’s 10th anniversary spotlights TPP’s threat to affordable life-saving drugs
Ten years ago today, in the dead of night, Congress passed the US-Central America Free Trade Agreement by two votes. Lessons learned from the actual effects of CAFTA on access to affordable life-saving prescription drugs provide a vivid illustration of the impact of TPP-like rules on people and their health.
UNAIDS calls on trade negotiators to uphold governments’ commitments to public health and access to medicines
The Trans-Pacific Partnership Agreement reportedly contains provisions that would lead to higher drug prices, not just in the TPPA but in future trade agreements as well, UNAIDS warns.
Don’t trade away our lives, urge folk with HIV/Aids
As the negotiations for the Trans-Pacific Partnership Agreement (TPPA) enter what could be its last round, we as people living with HIV/Aids (PLHIV), urge the Malaysian government not to trade away our lives.
9 ways the TPP is bad for developing countries
Oone issue that has received comparatively little attention is how the Trans-Pacific Partnership is likely to impact the developing countries slated to join.
WHO warns govt about risks of FTAs
Experts say the government should carefully consider before signing free-trade agreements (FTA) - as people could be hurt by deals that prolong drug patents and restrict information about medicine.
Editorial: New Zealand must tread carefully on Trans Pacific Partnership
New Zealand needs to be ready to walk away from the Trans Pacific Partnership, says The Domion Post, worried about the impact of its drug patenting rules and investor-state dispute settlement mechanism.
Leaked: What’s in Obama’s trade deal
A recent draft of the Trans-Pacific Partnership free-trade deal would give US pharmaceutical firms unprecedented protections against competition from cheaper generic drugs, possibly transcending the patent protections in US law.
AFTINET: Reply to the Department of Foreign Affairs and Trade Myths and Realities document, June 2015
The Australian government misrepresents the claims of critics and fails to address substantial criticisms of the Trans Pacific Partnership, says civil society network AFTINET.
Pressure intensifies on India over software and pharma patent protection in key Asian trade negotiations
Recently leaked documents show that India’s policies on software and pharmaceutical patents are firmly on the RCEP agenda.
Trade deal widens health care gap
NZ is heading towards a two-tier health system, and it could get a whole lot worse, writes George Laking.